Bioanalytical, Cardiometabolic Phenotyping, Imaging and Histology Core
生物分析、心脏代谢表型、成像和组织学核心
基本信息
- 批准号:10630579
- 负责人:
- 金额:$ 26.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-15 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:Basic ScienceBehavioralBiochemicalBiological AssayBlood-Borne PathogensBusinessesCapitalCardiorenal syndromeCardiovascular DiseasesCenters of Research ExcellenceChargeChemistryClinicalCore FacilityCoupledDataDevelopmentDisciplineDiseaseEnsureEnzyme-Linked Immunosorbent AssayEquipmentExtramural ActivitiesFacultyFee-for-Service PlansFosteringFundingFunding AgencyGenerationsGeneticGoalsGrantHazardous ChemicalsHigh PrevalenceHistologicHistologyHistorically Black Colleges and UniversitiesHuman ResourcesImageImmunohistochemistryIn VitroIndividualIndustryInfrastructureInstitutionKidney DiseasesLaboratoriesMaintenanceMeasurementMentorsMetabolicMetabolic DiseasesMississippiModelingMorbidity - disease rateObesityPhasePhenotypePhysiologicalPoliciesPopulationPostdoctoral FellowProceduresPublicationsRadiationRadioimmunoassayRecoveryRegulationResearchResearch InfrastructureResearch MethodologyResearch PersonnelResourcesSafetyScientistServicesStandardizationStudentsSupervisionSystemTechnical ExpertiseTechnologyTestingTrainingUnited StatesUnited States National Institutes of HealthUniversitiesUpdatecardiometabolismcostdoctoral studentexperienceimprovedin vivoin vivo imaginginstrumentationmembermortalitymultidisciplinarynew technologynovel strategiespharmacologicpre-doctoralservice utilizationsuccess
项目摘要
CORE B – BIOANALYTICAL, CARDIOMETABOLIC PHENOTYPING, IMAGING AND HISTOLOGY CORE
PROJECT SUMMARY/ABSTRACT
The Cardiorenal and Metabolic Diseases Research Center (CMDRC) was established to enhance research
infrastructure and provide mentoring to increase the ability of CMDRC investigators to successfully compete for
independent NIH funding. The Bioanalytical, Cardiometabolic Phenotyping, Imaging and Histology Sub-Cores
were established during Phases 1 and 2 to serve as a resource for the CMDRC, and Core B has had a
transformative effect on COBRE Junior Investigators and Pilot Grant investigators, and other users of Core B.
During Phase 1 and Phase 2 of COBRE support, Core B established consolidated, highly specialized services
and state-of-the-art resources critical to cardiorenal and metabolic diseases researchers; technologies and
services that would otherwise not be available to individual investigators. Core B is staffed by professional
personnel who are not only capable of performing a variety of essential research services, but are also able to
provide training and assist in the development of new research methods to meet the changing needs of COBRE
investigators. Core B has multiple components that include: the Bioanalytical Sub-Core that provides centralized
radioimmunoassay (RIA), ELISA, and other chemistry analyses; the Cardiometabolic Phenotyping Sub-Core that
provides centrally located, state-of-the-art, highly specialized in vivo phenotypical testing to characterize
physiological and behavioral parameters in genetic and pharmacological research models of obesity,
cardiovascular and metabolic disease; and the Imaging and Histology Sub-Cores that provide access to state-
of–the-art imaging equipment as well as histology, immunohistochemistry, and other key services. Over 88
investigators from 18 basic science and clinical departments at UMMC and 11 researchers from 8 other
institutions including Jackson State University, a Historically Black Colleges and Universities (HBCUs), used
Core B services and resources. Usage of Core B facilitated the generation of >260 publications and the funding
of 135 extramural grants from NIH and other non-profit funding agencies. Establishment of Core B as a Fee-for
Service Recharge Center initiated our Business Plan for our Model for Sustainability. The incorporation of
Centralized Billing and initiation of an Online Core Management System coupled to the commitment by UMMC
for continued support for capital maintenance and updates for capital equipment, and the significant increase in
independent extramural funding by users of Core B that established our Research Pool will ensure long-term
sustainability. Core B will continue to build upon our success so we can provide continuous support for existing
infrastructure and expand Core offerings.
核心 B – 生物分析、心脏代谢表型、成像和组织学核心
项目概要/摘要
成立心肾及代谢疾病研究中心(CMDRC)以加强研究
基础设施并提供指导,以提高 CMDRC 调查员成功竞争的能力
独立的 NIH 资助。生物分析、心脏代谢表型、成像和组织学子核心。
是在第一阶段和第二阶段建立的,作为 CMDRC 的资源,核心 B 拥有
对 COBRE 初级研究者和 Pilot Grant 研究者以及 Core B 的其他用户产生变革性影响。
在 COBRE 支持的第一阶段和第二阶段,核心 B 建立了整合的、高度专业化的服务
对心肾和代谢疾病研究人员至关重要的最先进的资源;
核心 B 配备了专业人员,否则这些服务将无法提供给个人调查员。
不仅能够执行各种基本研究服务的人员,而且还能够
提供培训并协助开发新的研究方法,以满足 COBRE 不断变化的需求
核心 B 具有多个组件,其中包括: 提供集中化的生物分析子核心。
放射免疫分析 (RIA)、ELISA 和其他化学分析;心脏代谢表型分型核心
提供位于中心的、最先进的、高度专业化的体内表型测试来表征
肥胖遗传和药理学研究模型中的生理和行为参数,
心血管和代谢疾病;以及提供状态访问的成像和组织学子核心
最先进的成像设备以及组织学、免疫组织化学和其他关键服务 超过 88 个。
来自 UMMC 18 个基础科学和临床部门的研究人员以及来自其他 8 个部门的 11 名研究人员
包括杰克逊州立大学在内的一所历史悠久的黑人学院和大学 (HBCU) 等机构使用
核心 B 服务和资源的使用促进了超过 260 种出版物的产生和资金筹集。
来自 NIH 和其他非营利资助机构的 135 项校外赠款作为建立核心 B 的费用。
服务充值中心启动了我们的可持续发展模式业务计划。
集中计费和启动在线核心管理系统以及 UMMC 的承诺
持续支持资本维护和资本设备更新,以及显着增加
建立我们研究池的核心 B 用户的独立外部资助将确保长期
核心 B 将继续在我们的成功基础上继续发展,以便我们能够为现有的业务提供持续的支持。
基础设施并扩展核心产品。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Barbara T Alexander其他文献
Barbara T Alexander的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Barbara T Alexander', 18)}}的其他基金
Hypertension in Adult IUGR Offspring: Beneficial Effects of Perinatal Intervention
成年 IUGR 后代的高血压:围产期干预的有益效果
- 批准号:
10326824 - 财政年份:2019
- 资助金额:
$ 26.43万 - 项目类别:
Hypertension in Adult IUGR Offspring: Beneficial Effects of Perinatal Intervention
成年 IUGR 后代的高血压:围产期干预的有益效果
- 批准号:
9903661 - 财政年份:2019
- 资助金额:
$ 26.43万 - 项目类别:
Hypertension in Adult IUGR Offspring: Beneficial Effects of Perinatal Intervention
成年 IUGR 后代的高血压:围产期干预的有益效果
- 批准号:
10064105 - 财政年份:2019
- 资助金额:
$ 26.43万 - 项目类别:
Core B - Bioanalytical, Mass Spectroscopy, Imaging and Histology Core
核心 B - 生物分析、质谱、成像和组织学核心
- 批准号:
10159919 - 财政年份:2013
- 资助金额:
$ 26.43万 - 项目类别:
Core B - Bioanalytical, Mass Spectroscopy, Imaging and Histology Core
核心 B - 生物分析、质谱、成像和组织学核心
- 批准号:
10403630 - 财政年份:2013
- 资助金额:
$ 26.43万 - 项目类别:
相似国自然基金
非晶态高聚物热力学本构模型及其在变形局域化行为表征方面的应用
- 批准号:11872170
- 批准年份:2018
- 资助金额:63.0 万元
- 项目类别:面上项目
单分散温度/pH双重响应的Janus微/纳米凝胶的制备、组装行为及在介入栓塞材料方面的应用研究
- 批准号:51103051
- 批准年份:2011
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
智力超常儿童的基因分型的初步研究
- 批准号:30670716
- 批准年份:2006
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
NIMH SYNTHESIS AND DISTRIBUTION OF DRUGS OF ABUSE AND RELATED COMPOUNDS. JUNE 16, 2023 - JUNE 15, 2024. TASK ORDER 75N95023F00002 (TO5). N01DA-22-8944.
NIMH 滥用药物及相关化合物的合成和分销。
- 批准号:
10933157 - 财政年份:2023
- 资助金额:
$ 26.43万 - 项目类别:
Identification of Genetic Variants that Influence Compulsive Alcohol Intake in Outbred Rats
影响近交系大鼠强迫性饮酒的遗传变异的鉴定
- 批准号:
10585109 - 财政年份:2023
- 资助金额:
$ 26.43万 - 项目类别:
Unlocking the Chemical Space of Cancer-Associated Perturbations
解锁癌症相关扰动的化学空间
- 批准号:
10478520 - 财政年份:2022
- 资助金额:
$ 26.43万 - 项目类别:
Changes in synaptic vesicle-binding of alpha-synuclein in the central and enteric nervous system
中枢和肠神经系统中α-突触核蛋白突触小泡结合的变化
- 批准号:
10527040 - 财政年份:2022
- 资助金额:
$ 26.43万 - 项目类别: